3eo9
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | + | {{Seed}} | |
| + | [[Image:3eo9.jpg|left|200px]] | ||
| - | The | + | <!-- |
| + | The line below this paragraph, containing "STRUCTURE_3eo9", creates the "Structure Box" on the page. | ||
| + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| + | or leave the SCENE parameter empty for the default display. | ||
| + | --> | ||
| + | {{STRUCTURE_3eo9| PDB=3eo9 | SCENE= }} | ||
| - | + | ===Crystal structure the Fab fragment of Efalizumab=== | |
| - | Description: Crystal structure the Fab fragment of Efalizumab | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | + | <!-- |
| + | The line below this paragraph, {{ABSTRACT_PUBMED_19258452}}, adds the Publication Abstract to the page | ||
| + | (as it appears on PubMed at http://www.pubmed.gov), where 19258452 is the PubMed ID number. | ||
| + | --> | ||
| + | {{ABSTRACT_PUBMED_19258452}} | ||
| + | |||
| + | ==About this Structure== | ||
| + | 3EO9 is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3EO9 OCA]. | ||
| + | |||
| + | ==Reference== | ||
| + | <ref group="xtra">PMID:19258452</ref><references group="xtra"/> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Ding, J.]] | ||
| + | [[Category: Li, S.]] | ||
| + | [[Category: Antibody]] | ||
| + | [[Category: Efalizumab]] | ||
| + | [[Category: Fab]] | ||
| + | [[Category: Immune system]] | ||
| + | |||
| + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Apr 15 10:28:04 2009'' | ||
Revision as of 07:28, 15 April 2009
Crystal structure the Fab fragment of Efalizumab
Template:ABSTRACT PUBMED 19258452
About this Structure
3EO9 is a 2 chains structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Li S, Wang H, Peng B, Zhang M, Zhang D, Hou S, Guo Y, Ding J. Efalizumab binding to the LFA-1 alphaL I domain blocks ICAM-1 binding via steric hindrance. Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4349-54. Epub 2009 Mar 3. PMID:19258452
Page seeded by OCA on Wed Apr 15 10:28:04 2009
Categories: Homo sapiens | Ding, J. | Li, S. | Antibody | Efalizumab | Fab | Immune system
